Diversified Healthcare Trust (DHCNL) EBIT (2009 - 2026)

Diversified Healthcare Trust (DHCNL) has reported EBIT for 18 consecutive years, with -$67.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 42.84% year-over-year to -$67.2 million; the trailing twelve-month figure through Jun 2026 stood at -$425.6 million (up 12.93% YoY), and the FY2025 full-year result was -$523.0 million, down 17.61% from the prior year.
• EBIT grew to -$67.2 million in Q2 2026 per DHCNL's latest filing, from -$75.9 million in the prior quarter.
• Across five years, EBIT topped out at $295.7 million in Q1 2022 and bottomed at -$190.1 million in Q3 2025.
• Historically, EBIT has averaged -$55.8 million across 5 years, with a median of -$71.6 million in 2026.
• The sharpest annual moves came in 2022 and 2024: EBIT surged 5150.77% in 2022, then plunged 2326.63% in 2024.
• Over 5 years, EBIT stood at -$13.5 million in 2022, then plunged by 130.22% to -$31.0 million in 2023, then slumped by 307.32% to -$126.5 million in 2024, then rose by 26.99% to -$92.3 million in 2025, then climbed by 27.18% to -$67.2 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered -$67.2 million, -$75.9 million, and -$92.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.